Workflow
DeepGlint(688207)
icon
Search documents
格灵深瞳:格灵深瞳关于收购深圳市国科亿道科技有限公司部分股权并增资的进展暨完成工商变更的公告
2024-12-25 11:11
统一社会信用代码:91440300MA5ECU516L 证券代码:688207 证券简称:格灵深瞳 公告编号:2024-051 北京格灵深瞳信息技术股份有限公司 关于收购深圳市国科亿道科技有限公司部分股权并增资 的进展暨完成工商变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 北京格灵深瞳信息技术股份有限公司(以下简称"公司")于2024年11月25日 召开第二届董事会第八次会议,审议通过了《关于收购深圳市国科亿道科技有限公 司部分股权并增资的议案》,同意公司以增资及收购股权的方式取得深圳市国科亿 道科技有限公司部分股权,其中以5,000万元对标的公司进行增资,以1,032.8352 万元受让国科亿道部分股东持有的标的公司股权,同时与标的公司的部分股东签署 《一致行动协议》,实现对标的公司的控制。具体内容详见公司于2024年11月26日 在上海证券交易所网站(www.sse.com.cn)披露的《北京格灵深瞳信息技术股份有 限公司关于收购深圳市国科亿道科技有限公司部分股权并增资的公告》(公告编 号:2024-04 ...
格灵深瞳:格灵深瞳关于以集中竞价交易方式回购股份的进展公告
2024-12-02 08:56
证券代码:688207 证券简称:格灵深瞳 公告编号:2024-050 北京格灵深瞳信息技术股份有限公司 关于以集中竞价交易方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 回购方案首次披露日 | 2024/8/24 | | | --- | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | | 预计回购金额 | 4,000 万元 | 万元~8,000 | | 回购用途 | √用于员工持股计划或股权激励 | □减少注册资本 | | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | | 累计已回购股数 | 2,802,726 | 股 | | 累计已回购股数占总股本比例 | 1.08% | | | 累计已回购金额 | 3,655.35 | 万元 | | 实际回购价格区间 | 10.34 元/股 | 元/股~15.00 | 本事项具体内容详见公司分别于 2024 年 8 月 24 日、2024 年 8 月 29 日在上海 证券 ...
格灵深瞳:格灵深瞳关于公司总经理辞职及聘任总经理、副总经理的公告
2024-11-25 11:48
证券代码:688207 证券简称:格灵深瞳 公告编号:2024-049 北京格灵深瞳信息技术股份有限公司 关于公司总经理辞职及聘任总经理、副总经理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 北京格灵深瞳信息技术股份有限公司董事会 2024年11月26日 一、总经理辞职情况 北京格灵深瞳信息技术股份有限公司(以下简称"公司")于近日收到公司董 事长、总经理赵勇先生的书面辞职报告,因公司业务发展需要,赵勇先生申请辞去 公司总经理职务,根据《中华人民共和国公司法》《公司章程》等有关规定,赵勇 先生的辞职报告自送达董事会之日起生效。辞任总经理后,赵勇先生仍担任公司董 事长、董事会战略委员会委员(召集人)、董事会提名委员会委员、董事会薪酬与 考核委员会委员等职务,仍为公司核心技术人员,并担任公司首席科学家。 赵勇先生为公司实际控制人。截至本公告披露日,赵勇先生通过天津深瞳智数 科技中心(有限合伙)、天津灵瞳众智科技中心(有限合伙)、天津灵瞳莱客科技 中心(有限合伙)、天津灵瞳智源科技中心(有限合伙)、天津灵瞳数源科技中心 ...
格灵深瞳:格灵深瞳关于收购深圳市国科亿道科技有限公司部分股权并增资的公告
2024-11-25 11:48
48证券代码:688207 证券简称:格灵深瞳 公告编号:2024-048 北京格灵深瞳信息技术股份有限公司 关于收购深圳市国科亿道科技有限公司部分股权并 增资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 1、商誉减值风险 本次交易完成后,标的公司将成为公司控股子公司,本次交易属于非同一控 制下企业合并,公司资产负债表预计将产生 2,600 万元-3,100 万元商誉。根据 北京格灵深瞳信息技术股份有限公司(以下简称"公司"或"收购方")拟 以增资及收购股权的方式取得深圳市国科亿道科技有限公司(以下简称"标 的公司"或"国科亿道")部分股权,其中拟以 5,000 万元对标的公司进行 增资,以 1,032.8352 万元受让国科亿道部分股东持有的标的公司股权,同时 与标的公司的部分股东签署《一致行动协议》,实现对标的公司的控制(以 下简称"本次交易")。 本次交易完成后,公司将直接持有标的公司 23.4194%的股权,成为其第一大 股东,并通过一致行动关系取得标的公司 54.6792%的表决权,成为 ...
格灵深瞳:格灵深瞳关于注销部分募集资金专户的公告
2024-11-21 07:54
证券代码:688207 证券简称:格灵深瞳 公告编号:2024-047 北京格灵深瞳信息技术股份有限公司 关于注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 北京格灵深瞳信息技术股份有限公司(以下简称"公司")首次公开发行股票 募集资金按照相关法律、法规和规范性文件的规定在银行开立了募集资金专用账户。 公司首次公开发行募投项目"人工智能算法平台升级项目"和"人工智能创新应用 研发项目"已结项,"营销服务体系升级建设项目"已终止,因此公司于近日办理 完成了部分募集资金专用账户的注销手续,具体情况如下: 一、募集资金基本情况 经中国证券监督管理委员会《关于同意北京格灵深瞳信息技术股份有限公司首 次公开发行股票注册的批复》(证监许可〔2022〕64号)核准,公司首次向社会公 众公开发行人民币普通股(A股)46,245,205股,发行价为人民币39.49元/股,募 集资金总额为人民币182,622.31万元,扣除不含税券商承销费用和保荐费用 12,783.56万元后的募集资金为169,838.75万元, ...
格灵深瞳:格灵深瞳关于以集中竞价交易方式回购公司股份比例达到总股本1%暨回购进展公告
2024-11-19 08:31
关于以集中竞价交易方式回购公司股份比例达到总股本 1%暨 回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 回购方案首次披露日 | 2024/8/24 | | | --- | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | | 预计回购金额 | 4,000 万元 | 万元~8,000 | | 回购用途 | √用于员工持股计划或股权激励 | □减少注册资本 □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | | 累计已回购股数 | 2,802,726 | 股 | | 累计已回购股数占总股本比例 | 1.08% | | | 累计已回购金额 | 3,655.35 | 万元 | | 实际回购价格区间 | 10.34 元/股 | 元/股~15.00 | 一、 回购股份的基本情况 2024 年 8 月 23 日,公司召开第二届董事会第五次会议,审议通过了《关于以 集中竞价交易方式回购公司股份方案的议案》,同意公司使用自有资金以集中竞价 交易方式回购 ...
格灵深瞳:格灵深瞳关于召开2024年第三季度业绩说明会的公告
2024-11-11 07:52
证券代码:688207 证券简称:格灵深瞳 公告编号:2024-045 北京格灵深瞳信息技术股份有限公司 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: (http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络文字互动 投资者可于 2024 年 11 月 13 日(星期三)至 2024 年 11 月 19 日(星期 二)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过邮件(公 司投资者关系邮箱 ir@deepglint.com)进行提问,公司将在信息披露允许的范 围内对投资者普遍关注的问题进行回答。 北京格灵深瞳信息技术股份有限公司(以下简称"公司")已于 2024 年 10 月 26 日发布公司 2024 年第三季度报告,为便于广大投资者更全面深入地了解公 司 2024 年第三季度的经营成果、财务状况,公司计划于 2024 年 11 月 20 日 11:00-12:00 召开 2024 年第三季度业绩说明 ...
格灵深瞳:格灵深瞳关于以集中竞价交易方式回购股份的进展公告
2024-11-04 08:46
证券代码:688207 证券简称:格灵深瞳 公告编号:2024-044 关于以集中竞价交易方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 回购方案首次披露日 | 2024/8/24 | | | --- | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | | 预计回购金额 | 4,000 万元 | 万元~8,000 | | 回购用途 | √用于员工持股计划或股权激励 | □减少注册资本 | | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | | 累计已回购股数 | 1,916,088 | 股 | | 累计已回购股数占总股本比例 | 0.74% | | | 累计已回购金额 | 2,340.65 | 万元 | | 实际回购价格区间 | 10.34 元/股 | 元/股~14.00 | 一、 回购股份的基本情况 2024 年 8 月 23 日,公司召开第二届董事会第五次会议,审议通过了《关于以 集中竞价交易方式回购公司股份 ...
1027公告全知道
2024-10-27 16:26
Summary of Key Points from Conference Call Records Industry and Company Overview - **Industry**: Semiconductor and Advanced Manufacturing - **Companies Mentioned**: - **芯碁微装 (Xingqi Micro Equipment)**: Specializes in direct imaging equipment and related services for semiconductor and PCB industries - **荣科科技 (Rongke Technology)**: Focuses on smart healthcare and cloud services - **格灵深瞳 (Geling Deep Vision)**: Engages in AI and computer vision technologies - **河化股份 (Hehua Co., Ltd.)**: Involved in pharmaceutical intermediates and urea processing Core Insights and Arguments - **Xingqi Micro Equipment**: - Reported a revenue of **7.18 billion CNY** for the first three quarters, a **37.05%** year-on-year increase - Net profit reached **1.55 billion CNY**, up **30.94%** year-on-year - The company is expanding its product offerings in the semiconductor field, with applications in IC, MEMS, and advanced packaging [1][1][1] - **Rongke Technology**: - Plans to acquire controlling interest in Jingzai Information through a share issuance and cash payment - The company operates in two main segments: smart healthcare and cloud services, providing software products and solutions [2][2][2] - Actively expanding into digital health cities and enhancing its cloud service offerings [2][2][2] - **Geling Deep Vision**: - Aims to gain control of Guoke Yida through capital increase and equity acquisition - Focuses on providing AI solutions across various sectors, including finance and urban management [3][3][3] - **Hehua Co., Ltd.**: - Reported a revenue of **1.67 billion CNY** for the first three quarters, a **10.16%** year-on-year increase - Net profit surged to **79.29 million CNY**, reflecting a **2171.86%** increase year-on-year - The company specializes in pharmaceutical intermediates and is recognized as a key player in the chemical industry [4][4][4] Other Important but Potentially Overlooked Content - **Xingqi Micro Equipment** has a strong customer base among leading PCB and semiconductor companies, indicating a stable credit status among clients [1][1][1] - **Rongke Technology** is adapting its products to fit with domestic processors and operating systems, enhancing its competitive edge in the AI sector [2][2][2] - **Hehua Co., Ltd.** has been recognized as one of the top 500 chemical companies in China, highlighting its significance in the industry [5][5][5] - The conference call also noted various corporate actions, including share buybacks and acquisitions, which may impact stock performance and investor sentiment [6][6][6]
格灵深瞳(688207) - 2024 Q3 - 季度财报
2024-10-25 09:56
Revenue and Net Loss - Revenue for the third quarter was RMB 9.35 million, a decrease of 86.07% year-over-year[2] - Net loss attributable to shareholders for the third quarter was RMB 59.70 million[2] - Revenue for the first nine months of the year was RMB 60.66 million, a decrease of 72.99% year-over-year[2] - Net loss attributable to shareholders for the first nine months of the year was RMB 137.62 million[2] - Operating income for the first three quarters of 2024 was 60,664,318.37 RMB, a significant decrease from 224,593,156.74 RMB in the same period of 2023[15] - The company reported a net loss of -137,553,551.96 RMB for the first three quarters of 2024, compared to a net loss of -17,551,576.76 RMB in 2023[17] - Net loss attributable to parent company shareholders was -137,622,524.86 RMB, a significant increase from -17,279,004.54 RMB in the same period last year[19] - Total comprehensive income for the period was -137,313,122.61 RMB, compared to -17,644,124.26 RMB in the previous year[19] - Basic earnings per share were -0.53 RMB, down from -0.07 RMB in the previous year[19] R&D Expenses - R&D expenses for the third quarter were RMB 46.25 million, a decrease of 2.63% year-over-year[3] - R&D expenses as a percentage of revenue for the third quarter was 494.37%, an increase of 423.64 percentage points year-over-year[3] - R&D expenses for the first nine months of the year were RMB 140.01 million, an increase of 12.41% year-over-year[3] - R&D expenses as a percentage of revenue for the first nine months of the year was 230.80%, an increase of 175.34 percentage points year-over-year[3] - R&D expenses increased to 140,013,513.48 RMB in 2024 from 124,558,446.61 RMB in 2023, highlighting continued investment in innovation[17] Assets and Liabilities - Total assets at the end of the third quarter were RMB 2.27 billion, a decrease of 8.16% compared to the end of the previous year[3] - Total assets increased to 2,472,307,952.09 RMB from 2,270,649,132.99 RMB, reflecting growth in the company's asset base[14] - Total liabilities rose to 187,261,415.53 RMB from 130,797,207.93 RMB, indicating increased financial obligations[15] - Total equity attributable to shareholders increased to 2,284,240,368.83 RMB from 2,138,929,263.91 RMB, reflecting growth in shareholder value[15] - Contract liabilities decreased to 12,454,823.63 RMB from 7,678,488.26 RMB, indicating changes in advance payments from customers[14] Shareholder Information - Total number of ordinary shareholders at the end of the reporting period is 13,823[8] - Tianjin Shentong Zhishu Technology Center (Limited Partnership) holds 43,765,884 shares, accounting for 16.90% of total shares[8] - Tianjin Lingtong Zhongzhi Technology Center (Limited Partnership) holds 13,331,285 shares, accounting for 5.15% of total shares[8] - HSG CV IV Holdco IX, Ltd. holds 10,954,384 shares, accounting for 4.23% of total shares[8] - Zhen Partners I (HK) Limited holds 10,165,378 shares, accounting for 3.93% of total shares[8] - Shenzhen High-Tech Investment Group Co., Ltd. holds 6,800,916 shares, accounting for 2.63% of total shares[10] - Zhao Jianping holds 6,740,000 shares, accounting for 2.60% of total shares[10] - HYUNDAI MOTOR COMPANY holds 6,420,806 shares, accounting for 2.48% of total shares[10] Cash Flow and Financial Position - Monetary funds as of September 30, 2024, amount to 962,853,447.62 RMB[13] - Total current assets as of September 30, 2024, amount to 1,848,879,042.28 RMB[13] - Cash received from sales of goods and services dropped to 77,399,821.76 RMB from 200,473,722.32 RMB year-over-year[20] - Operating cash flow was negative at -118,682,760.45 RMB, worsening from -82,573,789.27 RMB in the prior year[20] - Investment cash flow was negative at -226,124,083.02 RMB, compared to -98,484,302.95 RMB in the same period last year[21] - Cash and cash equivalents decreased by 370,780,586.71 RMB, ending the period at 522,648,496.97 RMB[21] - Cash received from tax refunds decreased to 2,822,523.54 RMB from 7,926,289.81 RMB year-over-year[20] - Cash paid for employee compensation increased to 150,912,576.79 RMB from 141,496,597.52 RMB[20] - Cash outflow for investments surged to 3,823,750,000.00 RMB from 1,555,060,000.00 RMB in the prior year[21] Operating Costs and Expenses - Total operating costs for the first three quarters of 2024 were 209,292,440.25 RMB, down from 249,187,655.32 RMB in 2023[17] - Interest income for the first three quarters of 2024 was 25,816,835.80 RMB, down from 31,292,494.37 RMB in 2023[17] - The company's financial expenses showed a net benefit of -23,302,029.68 RMB in 2024, compared to -30,054,471.74 RMB in 2023[17] Revenue Decline Reasons - The decrease in revenue was mainly due to a decline in revenue from the smart finance sector[6]